BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28532223)

  • 1. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2.
    Li P; Zhou X; Qu D; Guo M; Fan C; Zhou T; Ling Y
    Drug Deliv; 2017 Nov; 24(1):834-845. PubMed ID: 28532223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
    Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased antitumor efficacy of ginsenoside Rh
    Xia X; Tao J; Ji Z; Long C; Hu Y; Zhao Z
    Drug Deliv; 2020 Dec; 27(1):1369-1377. PubMed ID: 32998576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
    Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
    Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
    Zhang C; Yu H; Hou J
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized preparation of celastrol-loaded polymeric nanomicelles using rotatable central composite design and response surface methodology.
    Peng X; Wang J; Song H; Cui D; Li L; Li J; Lin L; Zhou J; Liu Y
    J Biomed Nanotechnol; 2012 Jun; 8(3):491-9. PubMed ID: 22764419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy.
    Jin X; Yang Q; Cai N
    Int J Nanomedicine; 2018; 13():3827-3838. PubMed ID: 30013338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
    Liu X; Sun Y; Yue L; Li S; Qi X; Zhao H; Yang Y; Zhang C; Yu H
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive micelles self-assembled from polymer brush (PAE-
    Huang X; Liao W; Zhang G; Kang S; Zhang CY
    Int J Nanomedicine; 2017; 12():2215-2226. PubMed ID: 28356738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Mast Cells and Basophils with Anti-FcεRIα Fab-Conjugated Celastrol-Loaded Micelles Suppresses Allergic Inflammation.
    Peng X; Wang J; Li X; Lin L; Xie G; Cui Z; Li J; Wang Y; Li L
    J Biomed Nanotechnol; 2015 Dec; 11(12):2286-99. PubMed ID: 26510321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia
    Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
    Anticancer Agents Med Chem; 2019; 19(13):1633-1641. PubMed ID: 31272362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1.
    Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
    Anticancer Agents Med Chem; 2020; 20(4):495-503. PubMed ID: 31814556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.
    Allen SD; Liu YG; Kim T; Bobbala S; Yi S; Zhang X; Choi J; Scott EA
    Biomater Sci; 2019 Jan; 7(2):657-668. PubMed ID: 30601470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
    Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
    Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protopanaxadiol aglycone ginsenoside-polyethylene glycol conjugates: synthesis, physicochemical characterizations, and in vitro studies.
    Mathiyalagan R; Kim YJ; Wang C; Jin Y; Subramaniyam S; Singh P; Wang D; Yang DC
    Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1803-1809. PubMed ID: 26539976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and Characterization of Spray-Dried Inhalable Powders Containing Polymeric Micelles for Pulmonary Delivery of Paclitaxel in Lung Cancer.
    Rezazadeh M; Davatsaz Z; Emami J; Hasanzadeh F; Jahanian-Najafabadi A
    J Pharm Pharm Sci; 2018; 21(1s):200s-214s. PubMed ID: 30321135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery.
    Chen D; Yu H; Mu H; Li G; Shen Y
    Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):205-9. PubMed ID: 24823243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells.
    Ge G; Yan Y; Cai H
    Biol Pharm Bull; 2017 Dec; 40(12):2117-2124. PubMed ID: 28966297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
    Shin DH; Kwon GS
    Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.